Cargando…

Missed Opportunities? An Observational Analysis of Lung Cancer Screening Utilization Amongst Patients With Lung Cancer

Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. The U.S. Preventive Services Task Force (USPSTF) and National Comprehensive Cancer Network (NCCN) recommend annual low-dose CT chest (LDCT) for LC screening in high-risk adults who meet appropriate criteria, which primarily fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olazagasti, Coral, Ehrlich, Matthew, Kohn, Nina, Aviles, Karen, Hoilett, Aldane, Seetharamu, Nagashree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848039/ https://www.ncbi.nlm.nih.gov/pubmed/35157547 http://dx.doi.org/10.1177/10732748221077959

Ejemplares similares

One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst the Hispanic population
por: Olazagasti, Coral, et al.
Publicado: (2022)

Implementing physician education to increase lung cancer screening uptake
por: Olazagasti, Coral, et al.
Publicado: (2023)

Disparities in lung cancer screening rates among the Hispanic/LatinX population
por: Olazagasti, Coral, et al.
Publicado: (2021)

Disparities in Lung Cancer Screening in Puerto Rico: A United States Colony with Unequal Benefits
por: Olazagasti, Coral, et al.
Publicado: (2021)

Lung cancer screening guidelines are clear but are they being followed?
por: Olazagasti, Coral, et al.
Publicado: (2020)

Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies
por: Olazagasti, Coral, et al.
Publicado: (2020)

Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer
por: Newman, James, et al.
Publicado: (2020)

Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients
por: Neumann, Melissa, et al.
Publicado: (2021)

Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data
por: Lee, Chung-Shien, et al.
Publicado: (2021)

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer
por: Wang, Kevin Y, et al.
Publicado: (2021)

New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
por: Seetharamu, Nagashree, et al.
Publicado: (2017)

Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives
por: Fraser, Madison, et al.
Publicado: (2023)

Pretreatment nutritional status and response to checkpoint inhibitors in lung cancer
por: Lee, Chung-Shien, et al.
Publicado: (2020)

A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity
por: Lee, Chung-Shien, et al.
Publicado: (2020)

An Atypical Presentation of Lichen Planus-Like Reaction from Pembrolizumab
por: Lee, Matthew, et al.
Publicado: (2019)

Lung cancer screening in patients with head and neck cancer: an opportunity frequently missed
por: Macmillan, Mark Thomas
Publicado: (2023)

SAT-LB102 When the Answer Is Not in the First Look: An Unusual Presentation of Follicular Thyroid Carcinoma
por: Bernabe Ramirez, Carolina, et al.
Publicado: (2019)

Harmine loaded Au@MSNs@PEG@Asp6 nano-composites for treatment of spinal metastasis from lung adenocarcinoma by targeting ANXA9 in vivo experiment
por: Wang, Houlei, et al.
Publicado: (2023)

Fortune or failure: missed opportunities and chance discoveries
por: Kohn, Alexander
Publicado: (1989)

Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer
por: Chi, Jeffrey, et al.
Publicado: (2020)

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
por: Runcie, Karie, et al.
Publicado: (2018)

Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon’s two-stage trial
por: Koffler, Daniel, et al.
Publicado: (2023)

Lung donation and SARS‐CoV‐2 transmission: Missed detection versus missed opportunity?
por: Van Slambrouck, Jan, et al.
Publicado: (2022)

Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review
por: McGovern, Kerri, et al.
Publicado: (2019)

Missed Opportunities for the Diagnosis of Colorectal Cancer
por: Siminoff, Laura A., et al.
Publicado: (2015)

Work-Life Balance vs. Work-Life Integration: A Young Physician Mother’s Journey
por: Olazagasti, Coral, et al.
Publicado: (2022)

Going Back Home: Understanding Physician Migration to the United States
por: Olazagasti, Coral, et al.
Publicado: (2023)

Reevaluation of missed lung cancer with artificial intelligence
por: Sicular, Serge, et al.
Publicado: (2022)

Cancer Clinical Trials Accrual: Missed Opportunities to Address Disparities and Missed Opportunities to Improve Outcomes for All
por: Newman, Lisa A., et al.
Publicado: (2008)

Calcitriol and cancer therapy: A missed opportunity
por: Trump, Donald L.
Publicado: (2018)

Diagnosis of advanced cervical cancer, missed opportunities?
por: Mattern, Jérémie, et al.
Publicado: (2022)

Opportunities and Challenges of Kava in Lung Cancer Prevention
por: Freeman, Breanne, et al.
Publicado: (2023)

Alveolar macrophages in lung cancer: opportunities and challenges
por: Chang, Cheng-Yen, et al.
Publicado: (2023)

Missed Opportunities to Address Cardiovascular Disease Risk Factors amongst Adults Attending an Urban HIV Clinic in South Africa
por: Rabkin, Miriam, et al.
Publicado: (2015)

Age-period-cohort analysis of lung cancer mortality inequalities in Southern Spain: missed opportunities for implementing equitable tobacco control policies
por: Córdoba-Doña, Juan Antonio, et al.
Publicado: (2023)

Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy
por: Baik, Christina S., et al.
Publicado: (2012)

Challenges and research opportunities for lung cancer screening in China
por: Wang, Zixing, et al.
Publicado: (2018)

Radiogenomics in brain, breast, and lung cancer: opportunities and challenges
por: Singh, Apurva, et al.
Publicado: (2021)

Corrigendum: Alveolar macrophages in lung cancer: opportunities and challenges
por: Chang, Cheng-Yen, et al.
Publicado: (2023)

Facilitating early diagnosis of lung cancer amongst primary care patients: The views of GPs
por: Wagland, R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p9l0ubsrtquca5qgicbbbhn3cr